126
Views
2
CrossRef citations to date
0
Altmetric
Letters

Rituximab effectively reduces macrophage migration inhibitory factor in patients with active rheumatoid arthritis

, , , , , , & show all
Pages 242-243 | Accepted 03 Jan 2012, Published online: 09 Mar 2012
 

Acknowledgement

The study has been financially supported by Roche Pharma AG Germany.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.